Inflammation as a Risk Factor in Cardiotoxicity: An Important Consideration for Screening During Drug Development

• প্রধান লেখক: Chiara Campana (লেখক), Rafael Dariolli (লেখক), Mohamed Boutjdir (লেখক), Eric A. Sobie (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Numerous commonly prescribed drugs, including antiarrhythmics, antihistamines, and antibiotics, carry a proarrhythmic risk and may induce dangerous arrhythmias, including the potentially fatal Torsades de Pointes. For this reason, cardiotoxicity testing has become essential in drug development and a...